AVISA DIAGNOSTICS INC (FOGCF)

0.0000 0.0000 (0.00%) As of 10:42AM EDT. Market open.

AVISA DIAGNOSTICS INC

Royal Centre
Suite 2050 1055 West Georgia Street PO Box 11121
Vancouver, BC V6E 3P3
Canada

https://www.avisadx.com

Sector(s): 
Industry: 
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David S. Joseph	President, CEO & Chairman	114.26k	N/A	1943
Philip Ross	President	N/A	N/A	N/A
Dr. Graham Timmins Ph.D.	Chief Science Advisor & Member of Science Advisory Board	N/A	N/A	N/A
Dr. Richard K. Murray M.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and community-acquired pneumonia. It also provides bacterial infections, including COPD, cystic fibrosis (CF), non CF bronchiectasis, community acquired pneumonia, and tuberculosis. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Vancouver, Canada.

Corporate Governance

AVISA DIAGNOSTICS INC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.